Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 1997

View Archived Issues

Shaman: Q3 1997 highlights

TNFR:Fc evaluated in patients with heart failure

Sankyo synthesizes azole aromatase inhibitors

ACAT inhibitors described by Sankyo in patent literature

Suntory's penems are active against MRSA

New 5-LO inhibitors from Meiji Milk

Regeneron: Q3 1997 highlights

T Cell Sciences: Q3 1997 highlights

Xoma: Q3 1997 highlights

Guilford: Q3 1997 highlights

Neurex: Q3 1997 highlights

Promising clinical results reported for Avakine

Immunomedics issued U.S. patent for imaging and treatment of infections and inflammation

LeukoSite, Warner-Lambert and Kyowa Hakko chemokine drug discovery collaboration

TK inhibitors under development at Dr. Karl Thomae

CCK/gastrin receptor ligands from James Black Foundation

Antiinflammatory CRF analogues prepared at U of California

Conformationally constrained arginal thrombin inhibitors prepared at Lusofarmaco/Guidotti

Pharmacokinetics, peripheral antihistaminic and central effects of rupatadine in humans

Alendronate and etidronate prevent steroid-induced osteoporosis

Minocycline associated with marked long-term efficacy in early RA

Preclinical antiinflammatory effects demonstrated for CT-3

Novo Nordisk files for HRT product in U.S.

Cubist acquires rights to daptomycin

Atacand launched in Sweden

Second drug from Inhale/Baxter collaboration enters clinical testing

New formulation of amiodarone shows favorable hemodynamic effects

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...